SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

UPLOAD Filing

Vendome Acquisition Corp I
Date: June 20, 2025 · CIK: 0002055879 · Accession: 0000000000-25-006500

Regulatory Compliance Financial Reporting Risk Disclosure

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-286534

Date
June 20, 2025
Author
Division of
Form
UPLOAD
Company
Vendome Acquisition Corp I

Letter

Re: Vendome Acquisition Corp I Amendment No. 1 to Registration Statement on Form S-1 Filed June 6, 2025 File No. 333-286534 Dear Scott LaPorta:

June 20, 2025

Scott LaPorta Chief Executive Officer Vendome Acquisition Corp I 1090 Center Drive Park City, UT 84098

We have reviewed your amended registration statement and have the following comments.

Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response.

After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our May 12, 2025 letter.

Amendment No. 1 to Registration Statement on Form S-1 Risk Factors Our warrant agreement designates the courts . . . , page 80

1. We note this provision applies to federal securities law claims. As the provision applies to Securities Act claims, please also state that investors cannot waive compliance with the federal securities laws and the rules and regulations thereunder. In that regard, we note that Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce any duty or liability created by the Securities Act or the rules and regulations thereunder. Please also revise the warrant agreement filed as Exhibit 4.4 to address whether this applies to Securities Act claims. June 20, 2025 Page 2 Dilution, page 97

2. We note your response to our prior comment 5 and your revisions to your filing. Additionally, we note you have revised your filing elsewhere to include a discussion of a Working Capital Convertible Note that may be convertible into Class A ordinary shares. Please further expand your narrative disclosure to describe this potential source of future dilution, or tell us how you determined such revision is not necessary. Reference is made to Item 1602(c) of Regulation S-K.

Please contact William Demarest at 202-551-3432 or Jennifer Monick at 202-551- 3295 if you have questions regarding comments on the financial statements and related matters. Please contact Pearlyne Paulemon at 202-551-8714 or Mary Beth Breslin at 202- 551-3625 with any other questions.

Sincerely,
Division of
Corporation Finance
Office of Real
Estate & Construction
cc: Gil Savir

Show Raw Text
<DOCUMENT>
<TYPE>TEXT-EXTRACT
<SEQUENCE>2
<FILENAME>filename2.txt
<TEXT>
 June 20, 2025

Scott LaPorta
Chief Executive Officer
Vendome Acquisition Corp I
1090 Center Drive
Park City, UT 84098

 Re: Vendome Acquisition Corp I
 Amendment No. 1 to
 Registration Statement on Form S-1
 Filed June 6, 2025
 File No. 333-286534
Dear Scott LaPorta:

 We have reviewed your amended registration statement and have the
following
comments.

 Please respond to this letter by amending your registration statement
and providing
the requested information. If you do not believe a comment applies to your
facts and
circumstances or do not believe an amendment is appropriate, please tell us why
in your
response.

 After reviewing any amendment to your registration statement and the
information
you provide in response to this letter, we may have additional comments. Unless
we note
otherwise, any references to prior comments are to comments in our May 12, 2025
letter.

Amendment No. 1 to Registration Statement on Form S-1
Risk Factors
Our warrant agreement designates the courts . . . , page 80

1. We note this provision applies to federal securities law claims. As the
provision
 applies to Securities Act claims, please also state that investors
cannot waive
 compliance with the federal securities laws and the rules and
regulations thereunder.
 In that regard, we note that Section 22 of the Securities Act creates
concurrent
 jurisdiction for federal and state courts over all suits brought to
enforce any duty or
 liability created by the Securities Act or the rules and regulations
thereunder. Please
 also revise the warrant agreement filed as Exhibit 4.4 to address
whether this applies
 to Securities Act claims.
 June 20, 2025
Page 2
Dilution, page 97

2. We note your response to our prior comment 5 and your revisions to your
filing.
 Additionally, we note you have revised your filing elsewhere to include
a discussion
 of a Working Capital Convertible Note that may be convertible into Class
A ordinary
 shares. Please further expand your narrative disclosure to describe this
potential
 source of future dilution, or tell us how you determined such revision
is not necessary.
 Reference is made to Item 1602(c) of Regulation S-K.

 Please contact William Demarest at 202-551-3432 or Jennifer Monick at
202-551-
3295 if you have questions regarding comments on the financial statements and
related
matters. Please contact Pearlyne Paulemon at 202-551-8714 or Mary Beth Breslin
at 202-
551-3625 with any other questions.

 Sincerely,

 Division of
Corporation Finance
 Office of Real
Estate & Construction
cc: Gil Savir
</TEXT>
</DOCUMENT>